Advertisement
Trauma/Critical Care| Volume 169, ISSUE 5, P1206-1212, May 2021

Download started.

Ok

The role of bone marrow microRNA (miR) in erythropoietic dysfunction after severe trauma

Published:January 04, 2021DOI:https://doi.org/10.1016/j.surg.2020.11.029

      Abstract

      Background

      Previous data has shown that severe traumatic injury is associated with bone marrow dysfunction, which manifests as persistent injury-associated anemia. This study sought to identify whether the expression of erythropoiesis-related microRNAs were altered in the bone marrow of trauma patients to determine if these microRNAs play a role in persistent injury-associated anemia.

      Methods

      Bone marrow was collected from severely injured trauma patients who underwent fracture fixation as well as patients who underwent elective hip replacement. There were 27 trauma patients and 10 controls analyzed. Total RNA and microRNA were isolated from CD34-positive cells using the RNeasy Plus Mini kit, and genome-wide microRNA expression patterns were assayed. Genes with significant expression differences were found using BRB-ArrayTools with a significance of P < .01.

      Results

      There were marked differences in expression of 108 microRNAs in the trauma group when compared with hip replacement patients. Four of these microRNAs play a role in regulating erythropoiesis: microRNA-150, microRNA-223, microRNA15a, and microRNA-24. These microRNAs were all upregulated significantly, with trauma/hip replacement fold changes of 1.7, 1.8, 1.2, and 1.2 respectively, and all act to suppress or regulate erythropoiesis.

      Conclusion

      Assessment of the bone marrow microRNA profile in trauma patients compared to those undergoing elective hip replacement revealed the differential expression of microRNA-150, microRNA-223, microRNA-15a, and microRNA-24. These microRNAs all play a role in decreased erythroid progenitor cell growth and provide important insight to the erythropoietic dysfunction seen after trauma.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Fonseca R.B.
        • Mohr A.M.
        • Wang L.
        • et al.
        Adrenergic modulation of erythropoiesis following severe injury is mediated through bone marrow stroma.
        Surg Infect (Larchmt). 2004; 5: 385-393
        • Fonseca R.B.
        • Mohr A.M.
        • Wang L.
        • Sifri Z.C.
        • Rameshwar P.
        • Livingston D.H.
        The impact of a hypercatecholamine state on erythropoiesis following severe injury and the role of IL-6.
        J Trauma. 2005; 59 (discussion 889–890): 884-889
        • Bible L.E.
        • Pasupuleti L.V.
        • Gore A.V.
        • Sifri Z.C.
        • Kannan K.B.
        • Mohr A.M.
        Daily propranolol prevents prolonged mobilization of hematopoietic progenitor cells in a rat model of lung contusion, hemorrhagic shock, and chronic stress.
        Surgery. 2015; 158: 595-601
        • Livingston D.H.
        • Anjaria D.
        • Wu J.
        • et al.
        Bone marrow failure following severe injury in humans.
        Ann Surg. 2003; 238: 748-753
        • Hong S.H.
        • Kim K.S.
        • Oh I.H.
        Concise review: exploring miRNAs--toward a better understanding of hematopoiesis.
        Stem Cells. 2015; 33: 1-7
        • Jin P.
        • Wang E.
        • Ren J.
        • et al.
        Differentiation of two types of mobilized peripheral blood stem cells by microRNA and cDNA expression analysis.
        J Transl Med. 2008; 6: 39
        • Bissels U.
        • Wild S.
        • Tomiuk S.
        • et al.
        Combined characterization of microRNA and mRNA profiles delineates early differentiation pathways of CD133+ and CD34+ hematopoietic stem and progenitor cells.
        Stem Cells. 2011; 29: 847-857
        • Hattangadi S.M.
        • Wong P.
        • Zhang L.
        • Flygare J.
        • Lodish H.F.
        From stem cell to red cell: regulation of erythropoiesis at multiple levels by multiple proteins, RNAs, and chromatin modifications.
        Blood. 2011; 118: 6258-6268
        • Listowski M.A.
        • Heger E.
        • Boguslawska D.M.
        • et al.
        microRNAs: fine tuning of erythropoiesis.
        Cell Mol Biol Lett. 2013; 18: 34-46
        • Ash R.C.
        • Detrick D.A.
        • Zanjani E.D.
        Studies of human pluripotential hemopoietic stem cells (CFU-GEMM) in vitro.
        Blood. 1981; 58: 309-316
        • Lu J.
        • Guo S.
        • Ebert B.L.
        • et al.
        MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors.
        Dev Cell. 2008; 14: 843-853
        • Emambokus N.
        • Vegiopoulos A.
        • Harman B.
        • Jenkinson E.
        • Anderson G.
        • Frampton J.
        Progression through key stages of haemopoiesis is dependent on distinct threshold levels of c-Myb.
        EMBO J. 2003; 22: 4478-4488
        • Mukai H.Y.
        • Motohashi H.
        • Ohneda O.
        • Suzuki N.
        • Nagano M.
        • Yamamoto M.
        Transgene insertion in proximity to the c-myb gene disrupts erythroid-megakaryocytic lineage bifurcation.
        Mol Cell Biol. 2006; 26: 7953-7965
        • Fazi F.
        • Rosa A.
        • Fatica A.
        • et al.
        A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis.
        Cell. 2005; 123: 819-831
        • Fukao T.
        • Fukuda Y.
        • Kiga K.
        • et al.
        An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling.
        Cell. 2007; 129: 617-631
        • Sankaran V.G.
        • Menne T.F.
        • Scepanovic D.
        • et al.
        MicroRNA-15a and -16-1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13.
        Proc Natl Acad Sci U S A. 2011; 108: 1519-1524
        • Johnnidis J.B.
        • Harris M.H.
        • Wheeler R.T.
        • et al.
        Regulation of progenitor cell proliferation and granulocyte function by microRNA-223.
        Nature. 2008; 451: 1125-1129
        • Felli N.
        • Pedini F.
        • Romania P.
        • et al.
        MicroRNA 223-dependent expression of LMO2 regulates normal erythropoiesis.
        Haematologica. 2009; 94: 479-486
        • Warren A.J.
        • Colledge W.H.
        • Carlton M.B.
        • Evans M.J.
        • Smith A.J.
        • Rabbitts T.H.
        The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development.
        Cell. 1994; 78: 45-57
        • Wadman I.A.
        • Osada H.
        • Grutz G.G.
        • et al.
        The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins.
        EMBO J. 1997; 16: 3145-3157
        • Wang Q.
        • Huang Z.
        • Xue H.
        • et al.
        MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4.
        Blood. 2008; 111: 588-595
        • Shiozaki M.
        • Sakai R.
        • Tabuchi M.
        • et al.
        Evidence for the participation of endogenous activin A/erythroid differentiation factor in the regulation of erythropoiesis.
        Proc Natl Acad Sci U S A. 1992; 89: 1553-1556
        • Yu J.
        • Shao L.E.
        • Lemas V.
        • et al.
        Importance of FSH-releasing protein and inhibin in erythrodifferentiation.
        Nature. 1987; 330: 765-767
        • Liu Y.
        • Lai L.
        • Chen Q.
        • et al.
        MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN.
        J Immunol. 2012; 188: 5500-5510
        • Kim M.J.
        • Civin C.I.
        • Kingsbury T.J.
        MicroRNAs as regulators and effectors of hematopoietic transcription factors.
        Wiley Interdiscip Rev RNA. 2019; 10: e1537